[17] Gallbladder disease, including gallstones (cholelithiasis) and gallbladder inflammation (cholecystitis), has been observed with incretin-based therapies
Retatrutide Dosing: What You Need to Know Before Taking It Retatrutide is an investigational triple agonist medication generating significant interest for obesity and type 2 diabetes management
See our standard GLP-1 program Your clinician determines which approach, if any, is appropriate for you
The latest research from Numerator shows that 70% of individuals who anticipate using GLP-1 medications in the future say theyll be doing so for weight loss and not for diabetes, up from 34% of current users
Popular GLP-1 agonists include semaglutide (Wegovy, Ozempic) and liraglutide (Saxenda, Victoza)
Only GLP-1RA reduced the risk of nonfatal stroke (RR = 0.84), as compared with placebo